Schott

Stefan Brandl Named New CEO of Schott

Stefan Brandl has served as Schott's new CEO since November 1, 2026, succeeding Torsten Derr

Schott Pharma to Build New US Prefillable Syringe Manufacturing Facility

In a move to triple its production of glass and polymer syringes for the US market by 2030, Germany’s Schott Pharma announced plans to build its first US facility to manufacture prefillable polymer syringes that meet the need for deep-cold storage and transportation of mRNA medications.

News

Schott Expands Footprint in "Pharmerging" Markets with Investment in Indonesia

Top-Feature

INOSIM GmbH

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

JULABO GmbH

When Every Temperature Change Determines the Process

Expert Insights

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.